186 related articles for article (PubMed ID: 37440008)
21. Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium.
Bhosale P; Serban B; Bernstein PS
Arch Biochem Biophys; 2009 Mar; 483(2):175-81. PubMed ID: 18926795
[TBL] [Abstract][Full Text] [Related]
22. A novel fluorescence-based assay for measuring A2E removal from human retinal pigment epithelial cells to screen for age-related macular degeneration inhibitors.
Jin HL; Lee SC; Kwon YS; Choung SY; Jeong KW
J Pharm Biomed Anal; 2016 Jan; 117():560-7. PubMed ID: 26604166
[TBL] [Abstract][Full Text] [Related]
23. Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease.
Fontaine V; Monteiro E; Fournié M; Brazhnikova E; Boumedine T; Vidal C; Balducci C; Guibout L; Latil M; Dilda PJ; Veillet S; Sahel JA; Lafont R; Camelo S
Aging (Albany NY); 2020 Apr; 12(7):6151-6171. PubMed ID: 32255762
[TBL] [Abstract][Full Text] [Related]
24. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
25. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.
Bone RA; Landrum JT; Guerra LH; Ruiz CA
J Nutr; 2003 Apr; 133(4):992-8. PubMed ID: 12672909
[TBL] [Abstract][Full Text] [Related]
26. Characterization of dihydro-A2PE: an intermediate in the A2E biosynthetic pathway.
Kim SR; He J; Yanase E; Jang YP; Berova N; Sparrow JR; Nakanishi K
Biochemistry; 2007 Sep; 46(35):10122-9. PubMed ID: 17685561
[TBL] [Abstract][Full Text] [Related]
27. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
[TBL] [Abstract][Full Text] [Related]
28. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease.
Wu Y; Fishkin NE; Pande A; Pande J; Sparrow JR
J Biol Chem; 2009 Jul; 284(30):20155-66. PubMed ID: 19478335
[TBL] [Abstract][Full Text] [Related]
29. Suppressive Effect of
Kim DH; Choi YR; Shim J; Choi YS; Kim YT; Kim MK; Kim MJ
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283798
[TBL] [Abstract][Full Text] [Related]
30. Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT).
Kelly D; Nolan JM; Howard AN; Stack J; Akuffo KO; Moran R; Thurnham DI; Dennison J; Meagher KA; Beatty S
Br J Nutr; 2017 Jan; 117(1):108-123. PubMed ID: 28122649
[TBL] [Abstract][Full Text] [Related]
31. Can Diet Supplements of Macular Pigment of Lutein, Zeaxanthin, and Meso-zeaxanthin Affect Cognition?
Wang H; Wang G; Billings R; Li D; Haase SR; Wheeler PF; Vance DE; Li W
J Alzheimers Dis; 2022; 87(3):1079-1087. PubMed ID: 35431251
[TBL] [Abstract][Full Text] [Related]
32. Dietary modification of human macular pigment density.
Hammond BR; Johnson EJ; Russell RM; Krinsky NI; Yeum KJ; Edwards RB; Snodderly DM
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1795-801. PubMed ID: 9286268
[TBL] [Abstract][Full Text] [Related]
33. Photo-products of retinal pigment epithelial bisretinoids react with cellular thiols.
Yoon KD; Yamamoto K; Zhou J; Sparrow JR
Mol Vis; 2011; 17():1839-49. PubMed ID: 21850158
[TBL] [Abstract][Full Text] [Related]
34. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Nolan JM; Stack J; O'connell E; Beatty S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
[TBL] [Abstract][Full Text] [Related]
35. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
[TBL] [Abstract][Full Text] [Related]
36. A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration.
Yoon KD; Yamamoto K; Ueda K; Zhou J; Sparrow JR
PLoS One; 2012; 7(7):e41309. PubMed ID: 22829938
[TBL] [Abstract][Full Text] [Related]
37. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
38. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.
Bernstein PS; Khachik F; Carvalho LS; Muir GJ; Zhao DY; Katz NB
Exp Eye Res; 2001 Mar; 72(3):215-23. PubMed ID: 11180970
[TBL] [Abstract][Full Text] [Related]
39. Modulatory Effect of Carotenoid Supplement Constituting Lutein and Zeaxanthin (10:1) on Anti-oxidant Enzymes and Macular Pigments Level in Rats.
Madhavan J; Chandrasekharan S; Priya MK; Godavarthi A
Pharmacogn Mag; 2018; 14(54):268-274. PubMed ID: 29720843
[TBL] [Abstract][Full Text] [Related]
40. Dual
Dyka FM; Molday LL; Chiodo VA; Molday RS; Hauswirth WW
Hum Gene Ther; 2019 Nov; 30(11):1361-1370. PubMed ID: 31418294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
